How often does Gyre Therapeutics move more than the options market prices?

0 of the last 6 reports moved at least as far as the implied move.

GYRENasdaqPharmaceutical Preparations

Gyre Therapeutics, Inc. (GYRE) earnings date, market-implied expected move, and options open interest by expiry

4.45

+0.01 · +0.29%

Regular session12:24 ET

Open4.50Volume239,507Mkt cap$495.1MEPS-0.16

Day4.45 – 4.530%52-wk4.27 – 9.144%

GYRE

Gyre Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 6

after close · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

+4.22%

vs ±65.8% implied · ×0.06

shaded = implied · ▲▼ = realized

Aug 7 '26 · confirmed

Implied vs realized

Largest filed tie

—

13F top-10 QoQ

+12.41%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

58 managers

Top fund weight

0.00%

GYRE weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Gyre Therapeutics (GYRE) is expected to report on Nov 6 after close (estimated date).

Implied vs realized

8 reports

0 of 6≥ implied

avg implied: ±54.2%
avg realized: ±5.3%

Feb 18 '25Feb 18 '25confirmed—▲+6.01%—

Mar 17 '25Mar 17 '25confirmed—▼−30.21%—

May 9 '25May 9 '25confirmed±38.0%▲+0.53%×0.01

Aug 11 '25Aug 11 '25confirmed±51.5%▲+6.93%×0.13

Q3 FY25Nov 7 '25confirmed±71.0%▼−1.77%×0.02

Q1 FY26Mar 12 '26confirmed±56.7%▼−6.30%×0.11

May 7 '26May 7 '26confirmed±42.3%▼−12.06%×0.29

Q2 FY26Aug 7 '26confirmed±65.8%▲+4.22%×0.06

quarterimplied−75%0+75%realized×

Q2 FY26±65.8%▲+4.22%×0.06

May '26±42.3%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 1 expiry · Aug 31 close

1.00OI · 1 expiry · Aug 31 closeP/C open interest · Jan 15 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

1—Jan 1572d10%

ExpiryPutsCallsP/C

Jan 1572d1—10%1.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−49.03%as filednet margin · revenue +29.25% QoQ · −2.12% YoY

Revenue$29M+29.25%

Gross profit$27M92.41%+26.32%

Operating income−$14M−49.35%−53.53%

Pre-tax income−$14M−56.26%

Net income−$14M−49.03%−44.76%

Cost of revenue$2M+80.03%

Operating expenses$41M+34.63%

Tax−$164,000−126.41%

Other expense−$71,000−160.17%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 12:15 ET

Intraday

Event sensitivity

FOMC ×1.09· ±4.6% vs ±4.2% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±4.6%8 of 24×1.09

NFPjobs report±3.8%7 of 10×0.90

PPIproducer prices±2.7%3 of 10×0.63

PCEpersonal income & outlays±2.4%9 of 19×0.56

GDPgross domestic product±1.8%8 of 19×0.43

CPROFcorporate profits±1.7%5 of 12×0.39

CPIconsumer prices±1.6%6 of 10×0.37

Bar = avg |move| to ±5% · tick = ±4.2% avg day · ×base = |move| ÷ ±4.2% · min 6 releases

Earnings history

EPS -0.12 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 7 '26 · confirmed	-0.12	—
Q1 FY26	Mar 12 '26 · confirmed	-0.10	—
Q3 FY25	Nov 7 '25 · confirmed	0.03	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod